Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Telecare is a valuable tool for hypertension management, a systematic review and meta-analysis

Verberk, Willem J.a; Kessels, Alfons G.H.b; Thien, Theoc

doi: 10.1097/MBP.0b013e328346e092
Review Article
Buy

There is an increasing interest for using telecare(TC) in the management of hypertension. A systematic review to the use of blood pressure (BP) measurement in TC has been performed (Medline/PubMed, Embase, and Cochrane Library), selecting randomized clinical trials that compared TC with usual care (UC) for hypertension management (treatment and/or coaching). Nine randomized clinical trials were selected (n=2501, 61.4±0.6 years, 42±2.7% males). Overall there was a significant larger decrease in the TC group than in the UC group for systolic (5.2±1.5 mmHg; P<0.001) and diastolic BP (2.1±0.8 mmHg; P<0.01). When studies were separated for antihypertensive treatment modification during the study (yes or no), systolic BP decrease difference between the TC and UC groups (ΔTC-ΔUC) tended to be significantly lower (5.1±2.9 mmHg lower) with treatment modification compared with nontreatment modification in which the ΔTC-ΔUC was 8.6±2.4 mmHg, P=0.07. TC led to a greater decrease in systolic and diastolic BP than UC. The differences between TC and UC for systolic BP tend to become larger when no treatment modification is applied. TC seems a valuable tool for hypertension management.

aMicrolife Corporation Taipei, Taiwan

bDepartment of Clinical Epidemiology and Technology Assessment, University Hospital Maastricht

cDepartment of General Internal Medicine, Radboud University Nijmegen, Medical Center, Nijmegen, The Netherlands

Correspondence to Willem J Verberk, PhD, Department of Research and Development, Microlife Corporation, 9F, No 431, RuiGuang Road, R.O.C. 114, Taipei, Taiwan Tel: +31634486146; fax: +41 71 7277039; e-mail: Willem.verberk@microlife.ch

Received September 20, 2010

Accepted March 10, 2011

© 2011 Lippincott Williams & Wilkins, Inc.